welcome to DuchenneXchange
- a positively charged Duchenne muscular dystrophy community.- join today!
- login
Crispr Halted Muscular Dystrophy In Dogs. Someday, It Might Cure Humans.
Today, our partner Dr. Eric Olson and his team at Exonics, a company CureDuchenne helped form, published data in the online journal, Science that shows an increase in dystrophin restoration of 92% in the heart of the canine’s. As the only Duchenne nonprofit organization to support Dr. Eric Olson’s work through Exonics, and to provide the seed funding necessary to accelerate his work in this company, we could not be more thrilled. This is a true testament to the power of venture philanthropy and I want to thank each and every donor and supporter who has believed in our work, and we are grateful to Dr. Olson for his dedication to Duchenne patients. Although we still have a long way to go before we confirm this therapy will be safe and effective in humans, this dramatic dystrophin restoration offers hope to all families affected by this disease.
rareRelated
-
BioMarin snags cash as Sarepta skips Duchenne patent battleSarepta Therapeutics Inc. agreed to pay...
-
Concept of Gene Therapy for DMD: Jerry R. Mendell, MDhttps://www.youtube.com/watch?v=llqGu7oj...
-
Roche Letter to the Duchenne CommunityBy now, many have heard about Pfizer's d...
-
Capricor Receives Rare Pediatric Disease Designation from FDA for CAP-1002 for Patients With Duchenne Muscular Dystr...Capricor Therapeutics, Inc., a biotechno...
-
Molecular therapy in a novel translational large animal model for Duchenne muscular dystrophyThe development of efficient and safe st...
-
Long-Term Evaluation of AAV-CRISPR Genome Editing For Duchenne Muscular DystrophyDuchenne muscular dystrophy (DMD) is a m...
-
Givinostat in Duchenne’s Muscular Dystrophy Long-term Safety and Tolerability StudyThis is an open label, long-term safety,...
